United States Human Papillomavirus Vaccine Market Assessment, By Type [Tetravalent, Nonavalent, Bivalent, Quadrivalent], By Disease Indication [Cervical cancer, Anal cancer, Vulvar & Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Others], By Category [Prophylactic vaccine, Therapeutic vaccine], By Method of synthesis [Nucleic acid-based, Peptide-based, Protein-based, Cell-based, Live-vector vaccine], By Recipient [Male, Female, Gender-neutral], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy, Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, 2016-2030F